Table 4: Adverse drug reactions reporting among drug resistant tuberculosis patients registered on all-oral long-term regimens at 10 programmatic management of drug resistant tuberculosis sites of Punjab from July 2019 to December 2020 [n (%)].
![Table 4: Adverse drug reactions reporting among drug resistant tuberculosis patients registered on all-oral long-term regimens at 10 programmatic management of drug resistant tuberculosis sites of Punjab from July 2019 to December 2020 [<i>n</i> (%)].](articles/2023/16/2/images/AsianPacJTropMed_2023_16_2_58_370148_t5.jpg)
| Close | |
|
|
|
|
Table 4: Adverse drug reactions reporting among drug resistant tuberculosis patients registered on all-oral long-term regimens at 10 programmatic management of drug resistant tuberculosis sites of Punjab from July 2019 to December 2020 [n (%)].
|
|